98%
921
2 minutes
20
The oncogenic Epstein-Barr virus (EBV) evades the immune system but has an Achilles heel: its genome maintenance protein (GMP) EBNA1, which is essential for viral genome replication, but also highly antigenic. Hence, the virus evolved a mechanism to limit the translation of EBNA1 mRNA to the minimum level which allows EBNA1 to fulfil its essential function while minimizing production of EBNA1-derived antigenic peptides. This mechanism involves the binding of the arginine-glycine-rich (RGG) motif of nucleolin (NCL), a host protein, to RNA G-quadruplexes (rG4) of the viral EBNA1 mRNA. This binding is dependent on arginine methylation of NCL RGG. EBNA1 contains two RGG motifs suggesting it could also be involved in this mechanism. Here we show that EBNA1 binds directly to rG4 of its own mRNA and limits its own expression, depending on its RGG motifs and their arginine methylation. Furthermore, EBNA1 and NCL cooperate to bind to rG4 of EBNA1 mRNA. As the GMP function of EBNA1 has been previously associated to its ability to bind RNA in an rG4-dependent manner, our results suggest the existence of a ternary EBNA1/NCL/EBNA1 mRNA protein/RNA complex that serves for both EBNA1 GMP function and capacity to auto-limit its expression to evade the immune system.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12231556 | PMC |
http://dx.doi.org/10.1093/nar/gkaf586 | DOI Listing |
Infect Med (Beijing)
September 2025
College of Pharmacy, Chongqing Medical University, Chongqing 400016, China.
Background: Epstein-Barr Virus (EBV) is a widespread human γ-herpesvirus linked to cancers and autoimmune diseases, but limited comprehensive bibliometric analysis appear to have been conducted in this field.
Methods: Using Web of Science data, 16,318 EBV-related documents (2014-2023) were analyzed via VOSviewer, Bibliometrix, and Citespace following the Strengthening the Reporting of Observational Studies in Epidemiology reporting guideline.
Results: This cross-sectional bibliometric analysis of 16,318 EBV-related documents (2014-2023) revealed a consistent upward trend in annual publications, reflecting growing global interest in EBV research.
Nucleic Acids Res
June 2025
Univ Brest; Inserm UMR1078; Etablissement Français du Sang (EFS) Bretagne; CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, 22 avenue Camille Desmoulins, F-29200 Brest, France.
The oncogenic Epstein-Barr virus (EBV) evades the immune system but has an Achilles heel: its genome maintenance protein (GMP) EBNA1, which is essential for viral genome replication, but also highly antigenic. Hence, the virus evolved a mechanism to limit the translation of EBNA1 mRNA to the minimum level which allows EBNA1 to fulfil its essential function while minimizing production of EBNA1-derived antigenic peptides. This mechanism involves the binding of the arginine-glycine-rich (RGG) motif of nucleolin (NCL), a host protein, to RNA G-quadruplexes (rG4) of the viral EBNA1 mRNA.
View Article and Find Full Text PDFVaccines (Basel)
April 2025
Division of Pulmonary Medicine, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou 325000, China.
Epstein-Barr virus (EBV), a ubiquitous human herpesvirus, has been robustly linked to the pathogenesis of nasopharyngeal carcinoma (NPC). The mechanism of EBV-induced NPC involves complex interactions between viral proteins and host cell pathways. This review aims to comprehensively outline the mechanism of EBV-induced NPC and the latest advances in targeted EBV vaccines for prophylaxis and treatment.
View Article and Find Full Text PDFFront Immunol
May 2025
Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Background: High-dose glucocorticoids are the standard treatment for acute relapses in patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD). Therapeutic apheresis can be considered for the escalation of relapse therapy, but some patients still do not recover sufficiently. We aimed to explore the effects of apheresis on humoral and cellular immune parameters and to identify features that correlate with beneficial clinical outcomes.
View Article and Find Full Text PDFNeurogenetics
July 2024
Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo State, 200005, Nigeria.
Multiple sclerosis (MS), an intricate neurological disorder, continues to challenge our understanding of the pivotal interplay between the immune system and the central nervous system (CNS). This condition arises from the immune system's misdirected attack on nerve fiber protection, known as myelin sheath, alongside nerve fibers themselves. This enigmatic condition, characterized by demyelination and varied clinical manifestations, prompts exploration into its multifaceted etiology and potential therapeutic avenues.
View Article and Find Full Text PDF